NCT06781060 Effect of Nerve Stimulation on Sciatic Nerve Injury Pediatric Patients
| NCT ID | NCT06781060 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azeem Hospital, Multan |
| Condition | Leg Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-11-18 |
| Primary Completion | 2025-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-11-18 with a primary completion date of 2025-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Brief Summary The goal of this study is to learn if Faradic Nerve Stimulation (FNS) can help children recover from a condition called Post-Injection Sciatic Nerve Injury (PISNI). PISNI happens when the sciatic nerve, which controls muscles and sensation in the legs, gets injured from an injection that was given in the wrong place or in the wrong way. This injury can cause pain, muscle weakness, and problems moving the legs. The main questions this study aims to answer are: Can Faradic Nerve Stimulation help children with PISNI recover better than regular physiotherapy alone? Does FNS reduce pain and improve movement in children with this injury? What will happen in the study? Children with PISNI will be treated in one of two groups: Group A will receive Faradic Nerve Stimulation along with regular physiotherapy. Group B will receive only regular physiotherapy and a similar treatment called Transcutaneous Electrical Nerve Stimulation (TENS). Both treatments will be given by healthcare professionals in a safe and comfortable environment. Participants will be asked to attend therapy sessions for a few months and will be checked regularly to see how well they are recovering. Why is this study important? Post-Injection Sciatic Nerve Injury is common in children, especially in countries where healthcare providers may not be properly trained. This can lead to long-term problems, including pain and difficulty walking. Standard physiotherapy helps but doesn't always work well enough. By testing Faradic Nerve Stimulation, this study hopes to find a treatment that helps nerves heal faster and more completely, especially in children who need it most. The findings from this study could lead to better treatments for nerve injuries in children, particularly in areas where healthcare resources are limited. If FNS works well, it could be a new way to help children recover and live pain-free lives.
Eligibility Criteria
Inclusion Criteria: * Pediatric patients diagnosed with Post-Injection Sciatic Nerve Injury (PISNI) caused by improper intramuscular (IM) injections. * Children aged 3 to 19 years. * Parental consent for participation in the study. * Assent from the child (when applicable), depending on the age and understanding of the participant. Exclusion Criteria: * Children requiring surgical intervention for severe neurotmesis. * Patients with neurological or musculoskeletal conditions that may affect the outcomes (e.g., muscular dystrophy, multiple sclerosis). * Children who are unable to participate in physical therapy due to other medical conditions or severe limitations. * Children with severe systemic or other comorbid conditions that could interfere with study participation or outcome measures.
Contact & Investigator
Prof Dr Muhammad Zia Ul Haq Professor-Supervisor, PhD
STUDY DIRECTOR
Lincoln University College (LUC), Malaysia
Frequently Asked Questions
Who can join the NCT06781060 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 19 Years, studying Leg Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06781060 currently recruiting?
Yes, NCT06781060 is actively recruiting participants. Contact the research team at chaman@lincoln.edu.my for enrollment information.
Where is the NCT06781060 trial being conducted?
This trial is being conducted at Multan, Pakistan.
Who is sponsoring the NCT06781060 clinical trial?
NCT06781060 is sponsored by Azeem Hospital, Multan. The principal investigator is Prof Dr Muhammad Zia Ul Haq Professor-Supervisor, PhD at Lincoln University College (LUC), Malaysia. The trial plans to enroll 100 participants.